NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,046,612 | +0.9% | 10,275 | 0.0% | 0.24% | +4.0% |
| Q2 2023 | $1,036,850 | +9.7% | 10,275 | 0.0% | 0.23% | +5.1% |
| Q1 2023 | $945,300 | +1.4% | 10,275 | 0.0% | 0.22% | -2.7% |
| Q4 2022 | $932,148 | +19.4% | 10,275 | 0.0% | 0.22% | +15.0% |
| Q3 2022 | $781,000 | -10.1% | 10,275 | 0.0% | 0.19% | -4.0% |
| Q2 2022 | $869,000 | -3.7% | 10,275 | 0.0% | 0.20% | +14.2% |
| Q1 2022 | $902,000 | +0.3% | 10,275 | 0.0% | 0.18% | +4.8% |
| Q4 2021 | $899,000 | +13.2% | 10,275 | +5.8% | 0.17% | +7.7% |
| Q3 2021 | $794,000 | -19.2% | 9,710 | -9.9% | 0.16% | -16.6% |
| Q2 2021 | $983,000 | +6.7% | 10,772 | 0.0% | 0.19% | -0.5% |
| Q1 2021 | $921,000 | -9.4% | 10,772 | 0.0% | 0.19% | -14.9% |
| Q4 2020 | $1,017,000 | +1.7% | 10,772 | -6.3% | 0.22% | -9.1% |
| Q3 2020 | $1,000,000 | -0.5% | 11,502 | 0.0% | 0.24% | -8.3% |
| Q2 2020 | $1,005,000 | -10.9% | 11,502 | -16.0% | 0.26% | -22.5% |
| Q1 2020 | $1,128,000 | -13.0% | 13,687 | 0.0% | 0.34% | +8.9% |
| Q4 2019 | $1,296,000 | +4.3% | 13,687 | -4.3% | 0.31% | -2.2% |
| Q3 2019 | $1,243,000 | -9.5% | 14,302 | -4.9% | 0.32% | -11.3% |
| Q2 2019 | $1,373,000 | -2.3% | 15,032 | +2.8% | 0.36% | -9.3% |
| Q1 2019 | $1,406,000 | +13.8% | 14,622 | +1.5% | 0.40% | -1.2% |
| Q4 2018 | $1,236,000 | +25.7% | 14,402 | +26.3% | 0.40% | +49.6% |
| Q3 2018 | $983,000 | +46.3% | 11,407 | +28.1% | 0.27% | +34.3% |
| Q2 2018 | $672,000 | +99.4% | 8,902 | +113.5% | 0.20% | +79.5% |
| Q1 2018 | $337,000 | +5.6% | 4,170 | +9.7% | 0.11% | +8.7% |
| Q4 2017 | $319,000 | -2.1% | 3,800 | 0.0% | 0.10% | -8.0% |
| Q3 2017 | $326,000 | -1.5% | 3,800 | -4.0% | 0.11% | -8.2% |
| Q2 2017 | $331,000 | +29.8% | 3,960 | +16.3% | 0.12% | +23.2% |
| Q1 2017 | $255,000 | +7.6% | 3,405 | +4.6% | 0.10% | 0.0% |
| Q4 2016 | $237,000 | -3.3% | 3,255 | +4.8% | 0.10% | -10.0% |
| Q3 2016 | $245,000 | -4.3% | 3,105 | 0.0% | 0.11% | -5.2% |
| Q2 2016 | $256,000 | +13.8% | 3,105 | 0.0% | 0.12% | +6.4% |
| Q1 2016 | $225,000 | -15.7% | 3,105 | 0.0% | 0.11% | -16.2% |
| Q4 2015 | $267,000 | – | 3,105 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |